Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Ovarian Neoplasms × taxane × Clear all

Phase

Status

Completed 2 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Nivolumab 2 tivozanib 1 taxane 1 atezolizumab 1 X-Rays 1 Specimen Handling 1 Phantoms, Imaging 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Interviews as Topic 1 E-3810 1 CTLA-4 Antigen 1 Biopsy 1 Behavior Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711161 2024-01-23

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Green3Bio, Inc.

Phase 1 Suspended

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡